cyclin B Antibodies

Santa Cruz Biotechnology delivers a wide array of cyclin B monoclonal antibodies for research in cell cycle regulation and cancer biology. Cyclin B monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclin B is a crucial regulatory protein that plays a significant role in the transition from the G2 phase to mitosis, ensuring proper cell division. Cyclin B dysregulation is often associated with various cancers, making it an important target for therapeutic interventions and biomarker studies. Understanding cyclin B function and regulation is essential for elucidating the mechanisms of cell cycle control and tumorigenesis. Researchers worldwide rely on cyclin B monoclonal antibodies to investigate cell cycle checkpoints and their role in cancer development. Advanced research techniques utilizing cyclin B monoclonal antibodies have revealed important insights into cellular division mechanisms. Ongoing studies with cyclin B monoclonal antibodies continue to enhance our understanding of cancer progression and potential treatment strategies. Santa Cruz Biotechnology monoclonal antibodies for cyclin B support cutting-edge research that advances our knowledge of cell cycle regulation and cancer biology.